52 results about "Magnoflorine" patented technology

The invention relates to the natural medicament field, in particular to a method for separating and purifying coptis alkaloids by utilizing polyamide resin. The method is characterized in that polyamide is used to deal with coptis coarse extract, adding the mixture in a polyamide column, dichloromethane is used for elution or the mixed solvent of dichloromethane and methanol is used for gradient elution, the fractions are inspected through thin layer chromatography, the same fractions are combined to separate out seven alkaloids, namely berberine, palmatine, coptisine, columbamine, jatrorrhizine, magnoflorine and groenlandcine. The method has the advantages of simple process operation, low sample loss, higher separation efficiency and lower production cost.

The invention discloses a pharmaceutical composition for preventing and treating rheumatoid arthritis. The traditional Chinese medicine raw materials for constituting active ingredients of the pharmaceutical composition by weight are as follows: 5.5-6.0mg of berberine, 0.3-0.4mg of palmatine, 1.5-2.0mg of jatrorrhizine, 1.5-1.8mg of magnoflorine, 0.1-0.2mg of phellodendrine, 0.2-0.3mg of coptisine, 55-60mg of baicalin, 1.5-2.0mg of baicalein, 5.0-7.0mg of wogonoside, 0.03-0.05mg of wogonin, 20-25mg of geniposide, 0.1-0.2mg of crocin and 0.25-0.3mg of chlorogenic acid. The results of pharmacological tests show that the pharmaceutical composition can significantly reduce the disease severity of CIA mice with the rheumatoid arthritis, significantly improve the inflammation and the immune injury situation at lesion sites in comparison with a control group and be used for preparing drugs for preventing and treating the rheumatoid arthritis.

The invention relates to dicranostigma leptopodum extract and an extraction method and application thereof. Based on researches on the antimicrobial activity and active ingredients of dicranostigma leptopodum, it is found that the dicranostigma leptopodum extract has remarkable inhibitory activity for various plant pathogens and has the potential to prepare a plant antibacterial agent as an effective ingredient. Meanwhile, it is also found that the dicranostigma leptopodum extract contains multiple effective ingredients with magnoflorine as a majority. The invention further provides a method and process for quickly gathering the effective ingredients in the dicranostigma leptopodum.

The invention discloses an application of magnoflorine in preparation of a bone regulation drug synergist and a pharmaceutical composition containing magnoflorine, and belongs to the technical field of biological medicines. The magnoflorine can be used for preparing the bone regulation drug synergist and can further be used for preparing a pharmaceutical composition with the effect of promoting osteoblast differentiation and mineralization. The pharmaceutical composition is prepared from one or two of psoralen and sweroside, and magnoflorine. The magnoflorine can be widely applied to the field of medicines, and can provide a new medicine source for the treatment of osteoporosis diseases.

The invention discloses a tissue culture method for Aristolochia heterophylla. Aristolochia heterophylla is an Aristolochiaceae plant and can be harvested in the four seasons, preferably in autumn. After the root of Aristolochia heterophylla is dug out, silt and fibrous roots on the root of Aristolochia heterophylla are removed; then the root is dried to a semi-dry state in the sun; and if the root has a diameter of 2.5 cm or more, the root is halved and dried in the sun. The drug properties of Aristolochia heterophylla are that the root of Aristolochia heterophylla is cylindrical, has light brown or light brown-yellow cortex, and has a light grayish yellow color after the cortex is peeled; Aristolochia heterophylla is firm and not prone to breakage; a broken surface is uneven and spinous; a cross section is offwhite to yellow white; and Aristolochia heterophylla is mealy and has thick cortex and bitter and slightly astringent taste. Aristolochia heterophylla mainly comprises aristolochic acid, beta-sitosterol, magnoflorine, allantoin, etc. Aristolochia heterophylla is mainly used for dispelling wind, promoting urination, eliminating dampness and easing pain and applied to treatment of oedema in the head, face, arms and legs and pain in the waist and the knee joints. According to the invention, an Aristolochia heterophylla stem with a bud is used as an explant and subjected to bud induction, bud proliferation culture, rooting culture, domestication, transplanting and the like so as to realize in-vitro regeneration of Aristolochia heterophylla; so the tissue culture method provides technical support for mass breeding, rapid propagation and novel species promotion of Aristolochia heterophylla.

The invention discloses a medicine composition for preventing and treating the depression and insomnia diseases and a preparation method and application thereof. The medicine composition is prepared from active ingredients of magnoflorine and spinosin in proportion. The invention further provides a method for separating and preparing magnoflorine and spinosin from spina date seeds through high-speed counter-current chromatography. According to the separation conditions, in a solvent system, the ratio of n-butyl alcohol to ethyl acetate to water is (1-3):(1-5):(2-7), the upper phase is a stationary phase, and the lower phase is a mobile phase. The preparation method has the advantages of being good in separation effect, large in preparation amount, low in loss, easy and convenient to operate, economical and environmentally friendly. Experimental studies of animal pharmacodynamics show that the composition has a remarkable improving and treating function on the depression and insomnia diseases.

The invention belongs to the technical field of fruit preservation and specifically discloses a preservation method for mangoes. The preservation method for mangoes comprises the following steps: 1) preparing a mango fresh-keeping agent: weighting 3-8 parts of oxalic acid, 1-4 parts of ferulic acid, 1-2 parts of nanometer zinc oxide, 1-3 parts of methyl jasmonate, 1-5 parts of phenylalanine and 2-4 parts of magnoflorine, in parts by weight, and then mixing and dissolving the weighted raw materials; 2) weighting 5-10 parts of chitosan, 1-4 parts of bentonite, 0.5-1 part of sodium dehydroacetateand 1-5 parts of plant extract powder, in parts by weight, and then mixing and dissolving the weighted raw materials. The preservation method for mangoes provided by the invention, the fresh-keepingagent and the fresh-keeping coating are combined for performing dual treatment on mangoes, so that respiration rate and transpiration of the mangoes during a storage process can be effectively reduced, and meanwhile, the antibacterial effect is excellent, so that the preservation effect of mangoes is effectively promoted.

The invention discloses a medicinal composition for preventing and treating neuropathic pain. The medicine is prepared from magnoflorine and ranunculin which are used as bulk pharmaceuticals in a certain proportion; the medicine can be prepared into various preparations by the conventional preparation process; the defects in the prior art are overcome; the medicinal composition which is used for treating neuropathic pain and is obvious in curative effect and safe is provided; the provided medicine is easy to prepare and low in cost; and the clinical test proves that the medicine has an obvious clinical effect on neuropathic pain comprising prosopalgia, ischialgia, sciatica of nerve roots, postherpetic neuralgia and diabetic peripheral polyneuritis and the like.

The invention belongs to the technical field of fruit fresh keeping and particularly discloses a mango preservative and a preparation method thereof. The mango preservative is prepared from the following raw materials including oxalic acid, ferulic acid, difenoconazole, phenylalanine, tryptophan, magnoflorine and a plant extracting solution; and the plant extracting solution is prepared from the following raw materials including flos caryophylli, spica prunellae, cortex cinnamomi, flos inulae and sisal hemp. Through mutual effect of various components, the mango preservative effectively improves the rate of intact fruit of mango storage, lowers the weight loss ratio, prolongs the fresh keeping time, and is good in fresh keeping effect.

The invention discloses a cortex phellodendron chinese identification method. According to the identification method, cortex phellodendron chinese is used for preparing a solution of a test product, solutions in which a berberine hydrochloride reference substance, a phellodendrine chloride reference substance and a magnoflorine reference substance are dissolved are used as reference substance solutions, and through high performance liquid chromatograph measurement, liquid chromatograms of the solution of the test product and the reference substance solutions are obtained respectively; the obtained liquid chromatograms are guided into a traditional Chinese medicine chromatograph fingerprint similarity evaluation system for analysis, through analysis, a cortex phellodendron chinese fingerprint is obtained, and hierarchical cluster analysis or principal component analysis or partial least square analysis is adopted for processing data of the cortex phellodendron chinese fingerprint, so that classification identification is conducted on the cortex phellodendron chinese or processed products of the cortex phellodendron chinese. According to the cortex phellodendron chinese identification method, on the basis of building the cortex phellodendron chinese fingerprint, the cortex phellodendron chinese index component content is measured, and by combining different chemical mode identification methods, the cortex phellodendron chinese, the processed products of the cortex phellodendron chinese and fake cortex phellodendri amurensis can be effectively identified and distinguished.

The invention relates to a UPLC specific chromatogram establishment method and a detection method of a radix semiaquilegiae medicinal material. The establishment method comprises the following steps:preparing a reference substance solution: taking a griffonilide reference substance, a lithospermoside reference substance and a magnoflorine reference substance, and adding a solvent for dissolutionto obtain a reference substance solution; preparing a test solution: taking a radix semiaquilegiae medicinal material powder, adding the solvent for extraction, filtering an extracting solution, and taking subsequent filtrate to obtain the test solution; and injecting the reference substance solution and the test solution into an ultra-high performance liquid chromatograph for detection, wherein amobile phase A adopted by the ultra-high performance liquid chromatograph is methanol, a mobile phase B adopted by the ultra-high performance liquid chromatograph is a phosphoric acid aqueous solution with a volume fraction of 0.03%-0.07%, and an elution mode is gradient elution. The establishing method can be used to obtain the specific chromatogram of the radix semiaquilegiae medicinal material, wherein 12 characteristic peaks are included. Besides, contents of griffonilide and magnoflorine in the radix semiaquilegiae medicinal material can be measured at the same time, the quality of the radix semiaquilegiae medicinal material can be comprehensively reflected, and the method is accurate, reliable, easy and convenient to operate and good in reproducibility.

The invention discloses magnoflorine preparations and preparation methods and application. One magnoflorine preparation is magnoflorine phospholipid complex, and the other magnoflorine preparation isnasal magnoflorine phospholipid complex-temperature sensitive in-situ gel. By the preparation methods, the characteristics of a good separating effect, large preparation amount, low loss and simple and convenient operation are achieved. In the related magnoflorine phospholipid complex, the mass ratio of magnoflorine to phospholipid is (1-4):(2-1), and the related preparation methods are achieved by dissolving and mixing components in an organic solvent according to a formula ratio and preparing at a proper temperature. The obtained magnoflorine phospholipid complex is then added into the temperature sensitive in-situ gel as an auxiliary material to obtain the magnoflorine phospholipid complex-temperature sensitive in-situ gel. Animal pharmacodynamic experimental studies show that the magnoflorine and two preparations thereof have significant improving and therapeutic effects on depression and insomnia.

The invention discloses a method for constructing a characteristic chromatogram of caulis sinomenii, which is characterized in that sinomenine, magnoflorine and clove resinol diglucoside are taken as characteristic components, common peaks of different original caulis sinomenii samples are confirmed by an efficient detection method, and the characteristic chromatogram is constructed. According to the method, samples with different basic sources can be distinguished, and alkaloid and lignan contained in the caulis sinomenii are taken as representative components, so that the product quality can be relatively comprehensively reflected; the method is suitable for rapid and comprehensive quality control of caulis sinomenii medicinal materials, decoction pieces, extracts, standard decoction, formula granules and standard samples, preparation intermediate products and finished products of classic famous prescriptions containing caulis sinomenii, and is efficient, convenient to operate and suitable for quality monitoring of continuous production.